A sequential and prospectively maintained database at the Royal Marsden Hospital, London, was retrospectively searched for women who had received neoadjuvant chemotherapy for primary operable breast ...

Ductal carcinoma in situ (DCIS) is a heterogeneous disease with multiple treatment options including breast-conserving surgery, the option of addition of radiation, and adjuvant endocrine therapy.

In this study, we reviewed the clinical, morphologic, and immunophenotypic data of DCIS cases sent for Oncotype DCIS at our institution, and analyzed whether any features were predictive of the ...

Ductal carcinoma in-situ (DCIS) accounts for one-fifth of breast cancer cases in the United States, according to the American Cancer Society. Given that it is a non-invasive form of breast cancer, ...